thymidine monophosphate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, YJ; Chang, EH; Choi, J; Kim, CH; Kim, DH; Kim, JS; Koo, BS; Lee, HC; Lim, J; Mok, CS; Park, AR | 1 |
1 other study(ies) available for thymidine monophosphate and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
dTMP imbalance through thymidylate 5'-phosphohydrolase activity induces apoptosis in triple-negative breast cancers.
Topics: Apoptosis; Cell Line, Tumor; Humans; Phosphoric Monoester Hydrolases; Thymidine Monophosphate; Triple Negative Breast Neoplasms | 2022 |